EA201591292A1 - Тапентадола малеат и его кристаллические формы - Google Patents
Тапентадола малеат и его кристаллические формыInfo
- Publication number
- EA201591292A1 EA201591292A1 EA201591292A EA201591292A EA201591292A1 EA 201591292 A1 EA201591292 A1 EA 201591292A1 EA 201591292 A EA201591292 A EA 201591292A EA 201591292 A EA201591292 A EA 201591292A EA 201591292 A1 EA201591292 A1 EA 201591292A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- tapentadola
- maleat
- crystalline forms
- preparation
- tapentadol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
- C07C215/54—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/13—Dicarboxylic acids
- C07C57/145—Maleic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Настоящее изобретение относится к новой и стабильной соли тапентадола, тапентадола малеату, ее полиморфным формам, а также к способам их получения, фармацевтическим композициям и их получению.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SI201300008 | 2013-01-10 | ||
SI201300032 | 2013-02-12 | ||
PCT/EP2014/050411 WO2014108514A1 (en) | 2013-01-10 | 2014-01-10 | Tapentadol maleate and crystalline forms thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201591292A1 true EA201591292A1 (ru) | 2015-11-30 |
EA030553B1 EA030553B1 (ru) | 2018-08-31 |
Family
ID=49955374
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201591292A EA030553B1 (ru) | 2013-01-10 | 2014-01-10 | Тапентадола малеат и его кристаллические формы |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP2943454B1 (ru) |
EA (1) | EA030553B1 (ru) |
SI (1) | SI2943454T1 (ru) |
WO (1) | WO2014108514A1 (ru) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3377049B1 (en) | 2015-11-17 | 2021-01-06 | MSN Laboratories Private Limited | Crystalline forms of tapentadol salts and process for preparation thereof |
EP4121013A1 (en) | 2020-03-16 | 2023-01-25 | Grünenthal GmbH | Scored tablet |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8288592B2 (en) * | 2009-09-22 | 2012-10-16 | Actavis Group Ptc Ehf | Solid state forms of tapentadol salts |
-
2014
- 2014-01-10 EP EP14700306.5A patent/EP2943454B1/en active Active
- 2014-01-10 EA EA201591292A patent/EA030553B1/ru unknown
- 2014-01-10 WO PCT/EP2014/050411 patent/WO2014108514A1/en active Application Filing
- 2014-01-10 SI SI201431896T patent/SI2943454T1/sl unknown
Also Published As
Publication number | Publication date |
---|---|
WO2014108514A1 (en) | 2014-07-17 |
SI2943454T1 (sl) | 2022-01-31 |
EP2943454A1 (en) | 2015-11-18 |
EA030553B1 (ru) | 2018-08-31 |
EP2943454B1 (en) | 2021-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA202190619A1 (ru) | Противовирусные соединения | |
EA201790781A3 (ru) | Противовирусные соединения | |
EA201790963A1 (ru) | Противовирусные соединения | |
EA201691216A1 (ru) | Композиции линаклотида с замедленным высвобождением | |
EA201791717A1 (ru) | Стабильные водные составы адалимумаба | |
EA201691988A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
EA201501142A1 (ru) | Гетероциклические соединения в качестве средств для борьбы с вредителями | |
EA201692301A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
EA201691259A1 (ru) | РЕГУЛЯТОРЫ Nrf2 | |
EA201591728A1 (ru) | Гетероциклические соединения и способы их применения | |
EA201490567A1 (ru) | Новые бициклические производные дигидрохинолин-2-она | |
EA201600506A1 (ru) | КРИСТАЛЛИЧЕСКИЙ КОМПЛЕКС 1-ЦИАНО-2-(4-ЦИКЛОПРОПИЛБЕНЗИЛ)-4-(β-D-ГЛЮКОПИРАНОЗ-1-ИЛ)БЕНЗОЛА, СПОСОБЫ ЕГО ПОЛУЧЕНИЯ И ЕГО ПРИМЕНЕНИЕ ДЛЯ ПРИГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ | |
EA201490474A1 (ru) | Аминохиназолины в качестве ингибиторов киназ | |
EA201590520A1 (ru) | Фармацевтическая композиция с покрытием, содержащая регорафениб | |
EA201592144A1 (ru) | Производное фенола, способ его получения и его применение в медицине | |
UA113062C2 (xx) | Похідні 5-фтор-4-іміно-3-(заміщеного)-3,4-дигідропіримідин-2(1h)ону | |
EA202091397A1 (ru) | Бензохинолоновые ингибиторы vmat2 | |
EA201490037A1 (ru) | Антагонисты trpv4 | |
EA201300034A1 (ru) | Фармацевтические композиции, содержащие иматиниб или его фармацевтически приемлемую соль, и способы их получения | |
EA201691141A1 (ru) | Соединения против ccr6 | |
EA201500931A1 (ru) | Производные пиридин-4-ила | |
EA201790570A1 (ru) | Модуляторы р2х7 | |
EA201391371A1 (ru) | Фармацевтическая композиция ситаглиптина | |
EA201591567A1 (ru) | Новые производные пиридина | |
EA201591380A1 (ru) | АНТАГОНИСТЫ Kv1.3 И СПОСОБЫ ИХ ПРИМЕНЕНИЯ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PD4A | Registration of transfer of a eurasian patent in accordance with the succession in title |